title: The effects of chronic cigarette smoking on gray matter volume: influence of sex.
abstract: Cigarette smoke contains nicotine and toxic chemicals and may cause significant neurochemical and anatomical brain changes. Voxel-based morphometry studies have examined the effects of smoking on the brain by comparing gray matter volume (GMV) in nicotine dependent individuals (NDs) to nonsmoking individuals with inconsistent results. Although sex differences in neural and behavioral features of nicotine dependence are reported, sex differences in regional GMV remain unknown. The current study examined sex differences in GMV in a large sample of 80 NDs (41 males) and 80 healthy controls (41 males) using voxel-based morphometry. Within NDs, we explored whether GMV was correlated with measures of cigarette use and nicotine dependence. High-resolution T1 structural scans were obtained from all participants. Segmentation and registration were performed in SPM8 using the optimized DARTEL approach. Covariates included age and an estimate of total global GMV. Differences were considered significant at p≤0.001, with a whole brain FWE-corrected cluster probability of p<0.025. Among NDs compared to Controls less GMV was observed in the thalamus and bilateral cerebellum and greater GMV was observed in the bilateral putamen and right parahippocampus. Lower thalamic GMV was observed in both female and male NDs compared to Controls. Female NDs also had lower GMV in the left cerebellum and in the ventral medial and orbitofrontal cortices with no areas of greater GMV. Male NDs had lower GMV in bilateral cerebellum and greater GMV in bilateral parahippocampus and left putamen. Within male NDs, GMV in the left putamen was correlated with number of pack years. This study, conducted in a large cohort, contributes to our knowledge of brain morphology in nicotine addiction and provides additional evidence of sex-specific effects on GMV in NDs. Identifying brain vulnerabilities with respect to sex provides a methodological framework for personalized therapies to improve relapse rates for both sexes.
authors.affiliation: Perelman School of Medicine at the University of Pennsylvania, Department of Psychiatry, Philadelphia, Pennsylvania, United States of America.
authors.forename: Teresa R
authors.initials: TR
authors.lastname: Franklin
authors.affiliation: Perelman School of Medicine at the University of Pennsylvania, Department of Psychiatry, Philadelphia, Pennsylvania, United States of America.
authors.forename: Reagan R
authors.initials: RR
authors.lastname: Wetherill
authors.affiliation: Perelman School of Medicine at the University of Pennsylvania, Department of Psychiatry, Philadelphia, Pennsylvania, United States of America.
authors.forename: Kanchana
authors.initials: K
authors.lastname: Jagannathan
authors.affiliation: Perelman School of Medicine at the University of Pennsylvania, Department of Psychiatry, Philadelphia, Pennsylvania, United States of America.
authors.forename: Barbara
authors.initials: B
authors.lastname: Johnson
authors.affiliation: Perelman School of Medicine at the University of Pennsylvania, Department of Psychiatry, Philadelphia, Pennsylvania, United States of America.
authors.forename: Joel
authors.initials: J
authors.lastname: Mumma
authors.affiliation: Perelman School of Medicine at the University of Pennsylvania, Department of Psychiatry, Philadelphia, Pennsylvania, United States of America.
authors.forename: Nathan
authors.initials: N
authors.lastname: Hager
authors.affiliation: Perelman School of Medicine at the University of Pennsylvania, Center for Functional Neuroimaging, Philadelphia, Pennsylvania, United States of America.
authors.forename: Hengyi
authors.initials: H
authors.lastname: Rao
authors.affiliation: Perelman School of Medicine at the University of Pennsylvania, Department of Psychiatry, Philadelphia, Pennsylvania, United States of America.
authors.forename: Anna Rose
authors.initials: AR
authors.lastname: Childress
mesh_terms: D000328:Adult; D002531:Cerebellum / Q000000981:diagnostic imaging* / Q000187:drug effects / Q000503:physiopathology; D005260:Female; D066128:Gray Matter / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011859:Radiography; D012727:Sex Characteristics; D012907:Smoking / Q000009:adverse effects*; D014029:Tobacco Use Disorder / Q000000981:diagnostic imaging* / Q000503:physiopathology
references.citation: Nicotine Tob Res. 2000 Aug;2(3):263-74
references.pmid: 11082827
references.citation: Brain Struct Funct. 2013 Jan;218(1):97-104
references.pmid: 22302433
references.citation: Addict Biol. 2014 Mar;19(2):294-304
references.pmid: 23061530
references.citation: Neuroscience. 1998 Nov;87(1):63-78
references.pmid: 9722142
references.citation: Neurotoxicol Teratol. 2002 May-Jun;24(3):369-84
references.pmid: 12009492
references.citation: Tob Control. 2003 Mar;12(1):21-7
references.pmid: 12612357
references.citation: Am J Psychiatry. 2001 Feb;158(2):188-97
references.pmid: 11156800
references.citation: Nat Neurosci. 2005 Nov;8(11):1481-9
references.pmid: 16251991
references.citation: Am J Psychiatry. 2005 Mar;162(3):567-77
references.pmid: 15741475
references.citation: Ann Neurol. 2007 Jan;61(1):37-46
references.pmid: 17187377
references.citation: J Pharmacol Exp Ther. 1997 Jul;282(1):7-13
references.pmid: 9223534
references.citation: Biol Psychiatry. 2011 Oct 15;70(8):785-793
references.pmid: 21757184
references.citation: Brain Cogn. 2004 Jun;55(1):11-29
references.pmid: 15134840
references.citation: MMWR Morb Mortal Wkly Rep. 2008 Nov 14;57(45):1226-8
references.pmid: 19008791
references.citation: Addict Behav. 2014 Apr;39(4):789-92
references.pmid: 24525300
references.citation: Biol Psychiatry. 2005 Aug 1;58(3):226-32
references.pmid: 15939406
references.citation: Psychiatry Res. 1992 Aug;45(2):115-21
references.pmid: 1488469
references.citation: Pharmacol Ther. 2009 May;122(2):125-39
references.pmid: 19268688
references.citation: Prog Neurobiol. 2000 May;61(1):75-111
references.pmid: 10759066
references.citation: Neuroimage. 2011 Jan 1;54(1):42-8
references.pmid: 20699124
references.citation: Cereb Cortex. 2000 Mar;10(3):318-25
references.pmid: 10731226
references.citation: Neuroscience. 2007 Feb 23;144(4):1153-9
references.pmid: 17197102
references.citation: Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14200-5
references.pmid: 16963565
references.citation: Nat Rev Neurosci. 2006 Jun;7(6):477-84
references.pmid: 16688123
references.citation: J Alzheimers Dis. 2011;23(4):655-64
references.pmid: 21157022
references.citation: PLoS One. 2011;6(11):e27440
references.pmid: 22076160
references.citation: Prog Neurobiol. 2004 Apr;72(5):341-72
references.pmid: 15157726
references.citation: Biol Sex Differ. 2013 Apr 29;4(1):9
references.pmid: 23628003
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):217-38
references.pmid: 19710631
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2004 Mar;28(2):319-27
references.pmid: 14751429
references.citation: Exp Clin Psychopharmacol. 2010 Dec;18(6):451-61
references.pmid: 21186920
references.citation: Neuroimage. 2001 Sep;14(3):685-700
references.pmid: 11506541
references.citation: Neuroimage. 2001 Jul;14(1 Pt 1):21-36
references.pmid: 11525331
references.citation: Br J Psychiatry. 2009 Nov;195(5):393-402
references.pmid: 19880927
references.citation: Addict Biol. 2013 Jan;18(1):147-60
references.pmid: 23167305
references.citation: Hum Brain Mapp. 2005 Apr;24(4):313-24
references.pmid: 15704151
references.citation: Biol Psychiatry. 2007 Oct 15;62(8):847-55
references.pmid: 17544382
references.citation: Am J Psychiatry. 2003 Feb;160(2):323-33
references.pmid: 12562580
references.citation: Learn Mem. 2009 Mar 24;16(4):248-66
references.pmid: 19318467
references.citation: Eur J Neurosci. 2006 Sep;24(6):1744-50
references.pmid: 17004938
references.citation: Aust J Public Health. 1995 Apr;19(2):129-31
references.pmid: 7786936
references.citation: Biol Psychiatry. 2004 Jan 1;55(1):77-84
references.pmid: 14706428
references.citation: Neuroimage. 2007 Oct 15;38(1):95-113
references.pmid: 17761438
references.citation: Neuroimage. 2011 Jan 1;54(1):131-41
references.pmid: 20688176
references.citation: Addict Biol. 2011 Apr;16(2):308-22
references.pmid: 21299752
references.citation: J Behav Med. 1989 Apr;12(2):159-82
references.pmid: 2668531
references.citation: Brain Struct Funct. 2012 Apr;217(2):517-22
references.pmid: 21909705
references.citation: Neuropsychol Rev. 2007 Sep;17(3):259-73
references.pmid: 17690985
references.citation: Brain Res. 1999 Dec 18;851(1-2):9-19
references.pmid: 10642823
references.citation: Neuroimage. 2013 Oct 1;79:42-51
references.pmid: 23631995
references.citation: J Gerontol B Psychol Sci Soc Sci. 2009 Nov;64 Suppl 1:i119-30
references.pmid: 19181686
references.citation: J Pers Soc Psychol. 1998 Jan;74(1):262-71
references.pmid: 9457787
references.citation: Neuropsychopharmacology. 2009 Sep;34(10):2252-64
references.pmid: 19494806
references.citation: Addict Biol. 2012 Nov;17(6):977-80
references.pmid: 20731627
references.citation: Drug Alcohol Depend. 2012 Oct 1;125(3):230-8
references.pmid: 22445480
references.citation: Br J Clin Pharmacol. 2006 Nov;62(5):546-51
references.pmid: 16796705
references.citation: Chest. 1993 Jun;103(6):1863-72
references.pmid: 8404115
references.citation: Neurology. 2001 Feb 13;56(3):368-75
references.pmid: 11171903
references.citation: Front Neuroendocrinol. 2008 Jan;29(1):36-47
references.pmid: 17904621
references.citation: Circulation. 1995 Jun 15;91(12):2891-7
references.pmid: 7796497